Analysis of all tumors as well as just those initiated with sgInert vectors (which are driven solely by oncogenic KRAS) confirmed that tumor burden, tumor number, and size were all reduced in the aged mice (Supplementary Fig. 4a–e). This evidence concerns the gene KRAS and neoplasm.